What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Posted inAlzheimer's Assn Alzheimer's Disease Amgen Inc Banner Alzheimer's Institute Biogen Inc Brain Clinical Trials Drugs (Pharmaceuticals) Eisai Co Ltd Elderly Eli Lilly and Company Food and Drug Administration Genetics and Heredity Government Accountability Office Hemorrhagic Stroke Institute for Clinical and Economic Review Kisunla Leqembi (Drug) Medicine and Health Novartis AG Retirement Communities and Assisted Living United States Villages, The (Fla)

What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
New Drug Approved for Early Alzheimer’s
Posted inAlzheimer's Disease Biogen Inc Brain Clinical Trials Dementia Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory Placebos Prices (Fares, Fees and Rates) your-feed-healthcare your-feed-science

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.